Product Code: ETC10162287 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Atherosclerotic Cardiovascular Disease Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Atherosclerotic Cardiovascular Disease Market - Industry Life Cycle |
3.4 Thailand Atherosclerotic Cardiovascular Disease Market - Porter's Five Forces |
3.5 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.6 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume Share, By Therapeutic Approach, 2021 & 2031F |
3.8 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume Share, By Risk Factors, 2021 & 2031F |
4 Thailand Atherosclerotic Cardiovascular Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of risk factors such as obesity and unhealthy diet leading to a rise in atherosclerotic cardiovascular diseases. |
4.2.2 Growing aging population in Thailand contributing to a higher incidence of cardiovascular diseases. |
4.2.3 Advancements in healthcare infrastructure and technology improving diagnosis and treatment options for atherosclerotic cardiovascular diseases. |
4.3 Market Restraints |
4.3.1 High cost associated with cardiovascular disease treatments and procedures limiting access to care for some individuals. |
4.3.2 Lack of awareness about preventive measures and lifestyle changes to reduce the risk of atherosclerotic cardiovascular diseases. |
4.3.3 Limited reimbursement policies and insurance coverage for cardiovascular disease treatments impacting affordability for patients. |
5 Thailand Atherosclerotic Cardiovascular Disease Market Trends |
6 Thailand Atherosclerotic Cardiovascular Disease Market, By Types |
6.1 Thailand Atherosclerotic Cardiovascular Disease Market, By Disease Area |
6.1.1 Overview and Analysis |
6.1.2 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Disease Area, 2021 - 2031F |
6.1.3 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Atherosclerosis, 2021 - 2031F |
6.1.4 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Coronary Artery Disease, 2021 - 2031F |
6.1.5 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Heart Attack, 2021 - 2031F |
6.2 Thailand Atherosclerotic Cardiovascular Disease Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Medical Therapy, 2021 - 2031F |
6.2.3 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Surgical Therapy, 2021 - 2031F |
6.2.4 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Preventive Medicine, 2021 - 2031F |
6.3 Thailand Atherosclerotic Cardiovascular Disease Market, By Therapeutic Approach |
6.3.1 Overview and Analysis |
6.3.2 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Statins, 2021 - 2031F |
6.3.3 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Angioplasty, 2021 - 2031F |
6.3.4 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Beta-blockers, 2021 - 2031F |
6.4 Thailand Atherosclerotic Cardiovascular Disease Market, By Risk Factors |
6.4.1 Overview and Analysis |
6.4.2 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Obesity, 2021 - 2031F |
6.4.3 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Hypertension, 2021 - 2031F |
6.4.4 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Diabetes, 2021 - 2031F |
7 Thailand Atherosclerotic Cardiovascular Disease Market Import-Export Trade Statistics |
7.1 Thailand Atherosclerotic Cardiovascular Disease Market Export to Major Countries |
7.2 Thailand Atherosclerotic Cardiovascular Disease Market Imports from Major Countries |
8 Thailand Atherosclerotic Cardiovascular Disease Market Key Performance Indicators |
8.1 Average wait time for cardiovascular disease diagnosis and treatment. |
8.2 Percentage of the population screened for cardiovascular disease risk factors. |
8.3 Adoption rate of innovative cardiovascular disease treatment methods. |
8.4 Patient satisfaction scores with cardiovascular disease care services. |
8.5 Rate of adherence to recommended lifestyle changes among individuals at risk for atherosclerotic cardiovascular diseases. |
9 Thailand Atherosclerotic Cardiovascular Disease Market - Opportunity Assessment |
9.1 Thailand Atherosclerotic Cardiovascular Disease Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.2 Thailand Atherosclerotic Cardiovascular Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Thailand Atherosclerotic Cardiovascular Disease Market Opportunity Assessment, By Therapeutic Approach, 2021 & 2031F |
9.4 Thailand Atherosclerotic Cardiovascular Disease Market Opportunity Assessment, By Risk Factors, 2021 & 2031F |
10 Thailand Atherosclerotic Cardiovascular Disease Market - Competitive Landscape |
10.1 Thailand Atherosclerotic Cardiovascular Disease Market Revenue Share, By Companies, 2024 |
10.2 Thailand Atherosclerotic Cardiovascular Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |